| FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial V Heinemann, LF von Weikersthal, T Decker, A Kiani, U Vehling-Kaiser, ... The lancet oncology 15 (10), 1065-1075, 2014 | 2049 | 2014 |
| Retinoic acid and arsenic trioxide for acute promyelocytic leukemia F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ... New England Journal of Medicine 369 (2), 111-121, 2013 | 1785* | 2013 |
| A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute … P Fenaux, C Chastang, S Chevret, M Sanz, H Dombret, E Archimbaud, ... Blood, The Journal of the American Society of Hematology 94 (4), 1192-1200, 1999 | 986 | 1999 |
| Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients N Schmitz, P Dreger, DC Linch, AH Goldstone, MA Boogaerts, ... The Lancet 347 (8998), 353-357, 1996 | 797 | 1996 |
| Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial RD Hofheinz, F Wenz, S Post, A Matzdorff, S Laechelt, JT Hartmann, ... The lancet oncology 13 (6), 579-588, 2012 | 687 | 2012 |
| Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group P Fenaux, MC Le Deley, S Castaigne, E Archimbaud, C Chomienne, ... | 622 | 1993 |
| EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update C Bokemeyer, MS Aapro, A Courdi, J Foubert, H Link, A Österborg, ... European Journal of Cancer 43 (2), 258-270, 2007 | 501 | 2007 |
| Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2 … C Röllig, H Serve, A Hüttmann, R Noppeney, C Müller-Tidow, U Krug, ... The lancet oncology 16 (16), 1691-1699, 2015 | 473 | 2015 |
| Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non–high-risk acute promyelocytic leukemia: final results of the … U Platzbecker, G Avvisati, L Cicconi, C Thiede, F Paoloni, M Vignetti, ... Journal of Clinical Oncology 35 (6), 605-612, 2017 | 436 | 2017 |
| Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation: Presented in part … P Reusser, H Einsele, J Lee, L Volin, M Rovira, D Engelhard, J Finke, ... Blood, The Journal of the American Society of Hematology 99 (4), 1159-1164, 2002 | 411 | 2002 |
| Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective … H Wandt, M Frank, G Ehninger, C Schneider, N Brack, A Daoud, ... Blood, The Journal of the American Society of Hematology 91 (10), 3601-3606, 1998 | 379 | 1998 |
| Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants R Hehlmann, M Lauseker, S Saußele, M Pfirrmann, S Krause, HJ Kolb, ... Leukemia 31 (11), 2398-2406, 2017 | 361 | 2017 |
| EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer C Bokemeyer, MS Aapro, A Courdi, J Foubert, H Link, A Österborg, ... European Journal of Cancer 40 (15), 2201-2216, 2004 | 361 | 2004 |
| Antimicrobial therapy of unexplained fever in neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology … H Link, A Böhme, OA Cornely, K Höffken, O Kellner, WV Kern, R Mahlberg, ... Annals of hematology 82, S105-S117, 2003 | 355 | 2003 |
| Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines M Aapro, Y Beguin, C Bokemeyer, M Dicato, P Gascón, J Glaspy, ... Annals of Oncology 29, iv96-iv110, 2018 | 331 | 2018 |
| Malignant melanoma S3‐guideline “diagnosis, therapy and follow‐up of melanoma” A Pflugfelder, C Kochs, A Blum, M Capellaro, C Czeschik, T Dettenborn, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11 (s6), 1-116, 2013 | 315 | 2013 |
| German S3-guideline" Diagnosis and treatment of esophagogastric cancer" M Moehler, SE Al-Batran, T Andus, M Anthuber, J Arends, D Arnold, ... Zeitschrift fur Gastroenterologie 49 (4), 461-531, 2011 | 310 | 2011 |
| September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents MS Aapro, H Link The oncologist 13 (S3), 33-36, 2008 | 280 | 2008 |
| Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group P Ljungman, D Engelhard, H Link, P Biron, L Brandt, S Brunet, ... Clinical Infectious Diseases 14 (4), 831-835, 1992 | 246 | 1992 |
| Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies HW Auner, C Tinchon, W Linkesch, A Tiran, F Quehenberger, H Link, ... Annals of hematology 82, 218-222, 2003 | 241 | 2003 |
Gerhard EhningerProfessor of Internal MedicineПодтвержден адрес электронной почты в домене cellex.me
